Medtronic plc (MDTC34) — Capital Reinvestment Ratio
Latest as of April 2026:
0.19x
Medtronic plc (MDTC34) has a Capital Reinvestment Ratio of 0.19x as of April 2026, meaning it reinvests 0% of its operating cash flow (R$2.57 Billion) in capital expenditures (R$488.00 Million). See MDTC34 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.19x
Capex / Operating Cash Flow
Operating Cash Flow
R$2.57 Billion
BRL
Capital Expenditures
R$488.00 Million
BRL
Data as of
Apr 2026
Most recent filing
Medtronic plc Capital Reinvestment Ratio (2019–2026)
This chart tracks Medtronic plc's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Medtronic plc (2019–2026)
Year-by-year Capital Reinvestment Ratio for Medtronic plc from 2019 to 2026. For live market cap and broader valuation context, see Medtronic plc stock valuation.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.26x | R$7.33 Billion | R$1.90 Billion | ▼ -1.6% |
| 2025 | 0.26x | R$7.04 Billion | R$1.86 Billion | ▲ +12.9% |
| 2024 | 0.23x | R$6.79 Billion | R$1.59 Billion | ▼ -3.2% |
| 2023 | 0.24x | R$6.04 Billion | R$1.46 Billion | ▲ +29.7% |
| 2022 | 0.19x | R$7.35 Billion | R$1.37 Billion | ▼ -14.2% |
| 2021 | 0.22x | R$6.24 Billion | R$1.35 Billion | ▲ +29.5% |
| 2020 | 0.17x | R$7.23 Billion | R$1.21 Billion | ▲ +3.6% |
| 2019 | 0.16x | R$7.01 Billion | R$1.13 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow